Effects of OROS methylphenidate (OROS MPH) treatment in children and adolescents with ADHD, mental retardation and epilepsy

被引：1
|
作者：
Kesic, A. [1 ]
Lakic, A. [1 ]
Dronjak, D. [2 ]
Stupar, D. [1 ]
机构：
[1] Sch Med, Inst Neurol & Psychiat Children & Adolescents, Belgrade, Serbia
[2] Gen Hosp, Krusevac, Serbia
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2012年 / 22卷
关键词：
D O I：
10.1016/S0924-977X(12)70659-4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S420 / S421
页数：2
相关论文
共 50 条
  • [41] Evaluation of once-a-day OROS® methylphenidate HCl (MPH) extended-release tablets versus MPH tid in children with ADHD in natural school settings
    Pelham, WE
    Hoffmann, MT
    Lock, T
    PEDIATRIC RESEARCH, 2000, 47 (04) : 31A - 31A
  • [42] Impact of ADHD treatment with a once-daily OROS® formulation of methylphenidate on tics
    Palumbo, DR
    Starr, HL
    PEDIATRIC RESEARCH, 2003, 53 (04) : 555A - 556A
  • [43] Changes in function and quality of life aspects in children with ADHD after transitioning onto OROS MPH
    Schaeuble, Barbara
    Mattejat, Fritz
    Rettig, Klaus
    Kordon, Andreas
    Berek, Michael
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2011, 20 (01) : S131 - S132
  • [44] Outcomes of OROS® methylphenidate compared with atomoxetine in children with ADHD: A multicenter, randomized prospective study
    Jason E. Kemner
    H. Lynn Starr
    Patrick E. Ciccone
    Christa G. Hooper-Wood
    R. Steve Crockett
    Advances in Therapy, 2005, 22 : 498 - 512
  • [45] Greater symptom improvement and response rates with OROS® MPH vs. atomoxetine in children with ADHD
    Kemner, JE
    Starr, HL
    Bowen, DL
    Ciccone, PL
    Lynch, JM
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S273 - S274
  • [46] Emergence of tics in children with ADHD:: Impact of once-daily OROS® methylphenidate therapy
    Palumbo, D
    Spencer, T
    Lynch, J
    Co-Chien, H
    Faraone, SV
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2004, 14 (02) : 185 - 194
  • [47] Once-daily OROS® methylphenidate:: Response in girls with ADHD
    Wolraich, M
    PEDIATRIC RESEARCH, 2004, 55 (04) : 2A - 2A
  • [48] OROS® MPH prescribing patterns among physician specialties treating ADHD
    Zhang, Huabin
    Starr, Harriette L.
    Jason, Kemner E.
    Kimberly, Cooper M.
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2006, 27 (05): : 442 - 442
  • [49] SUCCESSFUL TREATMENT OF SOMNAMBULISM WITH OROS-METHYLPHENIDATE
    Nigam, M.
    Zadra, A.
    Boucetta, S.
    Gibbs, S. A.
    Warby, S.
    Montplaisir, J.
    Desautels, A.
    SLEEP MEDICINE, 2019, 64 : S279 - S280
  • [50] OROS®-MPH in adolescents with ADHD transitioning from Atomoxetine or ER-MPH (medikinet retard®) -: a post-hoc analysis
    Adam, A.
    Haertling, E.
    Bogdanow, M.
    Mattejat, F.
    Hargarter, L.
    Schauble, B.
    EUROPEAN PSYCHIATRY, 2008, 23 : S394 - S394
12345